Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,079,000
+11,000 (1.03%)
Mar 12, 2025, 9:00 AM KST

Samsung Biologics Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
1,083,316857,691798,056393,589240,975
Upgrade
Depreciation & Amortization
599,101489,782308,264161,789143,688
Upgrade
Loss (Gain) From Sale of Assets
2,1993,8662,5887,4661,841
Upgrade
Asset Writedown & Restructuring Costs
62,655--725.891,352
Upgrade
Loss (Gain) From Sale of Investments
-597.28-5,152-72,653-269.12-303.96
Upgrade
Loss (Gain) on Equity Investments
-2,660499.42-27,260-13,85317,768
Upgrade
Provision & Write-off of Bad Debts
-6,38021,51122,4074,857-
Upgrade
Other Operating Activities
-33,004-711.89185,130135,132304.75
Upgrade
Change in Accounts Receivable
-450,99230,127-305,336-120,660-61,480
Upgrade
Change in Inventory
-236,200-273,896-179,912-370,571-184,885
Upgrade
Change in Accounts Payable
409,295267,037134,59421,06058,253
Upgrade
Change in Unearned Revenue
10.5827,19944,017--
Upgrade
Change in Other Net Operating Assets
232,511248,27643,151235,330-15,422
Upgrade
Operating Cash Flow
1,659,2551,666,229953,048454,596202,090
Upgrade
Operating Cash Flow Growth
-0.42%74.83%109.65%124.95%1890.33%
Upgrade
Capital Expenditures
-1,303,573-995,071-956,840-406,254-139,665
Upgrade
Sale of Property, Plant & Equipment
1,3892,81164.0137.6447.69
Upgrade
Cash Acquisitions
-601,956-1,071,525-1,081,821--
Upgrade
Sale (Purchase) of Intangibles
-73,952-110,254-52,386-14,898-8,901
Upgrade
Investment in Securities
734,318607,760-1,015,673-512,375-270,167
Upgrade
Other Investing Activities
-0-0178.52-0-
Upgrade
Investing Cash Flow
-1,243,776-1,566,305-3,106,477-933,489-418,686
Upgrade
Short-Term Debt Issued
237,000758,500593,75050,00030,000
Upgrade
Long-Term Debt Issued
892,65945,000211,903648,356499,952
Upgrade
Total Debt Issued
1,129,659803,500805,653698,356529,952
Upgrade
Short-Term Debt Repaid
-684,500-686,783-496,988-30,000-150,000
Upgrade
Long-Term Debt Repaid
-878,947-751,967-496,906-171,734-257,392
Upgrade
Total Debt Repaid
-1,563,447-1,438,750-993,894-201,734-407,392
Upgrade
Net Debt Issued (Repaid)
-433,788-635,250-188,241496,622122,560
Upgrade
Issuance of Common Stock
--3,200,751--
Upgrade
Other Financing Activities
-200-12,430-00
Upgrade
Financing Cash Flow
-433,788-635,0503,000,080496,622122,560
Upgrade
Foreign Exchange Rate Adjustments
41,59312,245-3,242831.1-2,215
Upgrade
Net Cash Flow
23,284-522,882843,40918,560-96,251
Upgrade
Free Cash Flow
355,682671,158-3,79248,34362,425
Upgrade
Free Cash Flow Growth
-47.00%---22.56%-
Upgrade
Free Cash Flow Margin
7.82%18.17%-0.13%3.08%5.36%
Upgrade
Free Cash Flow Per Share
4997.369429.82-54.32730.64943.48
Upgrade
Cash Interest Paid
62,08663,48633,94018,59415,630
Upgrade
Cash Income Tax Paid
307,026319,321188,47342,36938,429
Upgrade
Levered Free Cash Flow
55,875-446,65321,97862,86041,358
Upgrade
Unlevered Free Cash Flow
87,161-395,65562,01972,05251,411
Upgrade
Change in Net Working Capital
-40,552476,162-148,2134,403126,702
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.